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TRUS guided biopsyAbstract Objective: This study aimed to check the sensitivity of phased array surface coli of 3T
MRI, in pre-sampling diagnosis of prostate cancer, in an attempt to use it instead of endorectal coil.
Patients and methods: This was a prospective comparative study, included 20 male patients, pre-
sented with suspected prostate cancer due to unexplained high PSA. The study protocol was
approved by the ethics committee in Al-Mana General Hospital.
Results: Prostate cancer was correctly diagnosed by T2w sequence within 9 patients, 10 by
DW&T2w, 13 by T2w – DW-DCE and 14 by of T2w-DW-DCE-MRS sequences.
Conclusion: 3T MRI imaging using phased array surface coil is a useful diagnostic tool for detect-
ing prostate cancer, trustworthy when compared to endorectal approach.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Newly published international statistics had stated that pros-
tate cancer is gaining remarkable increased records. World-
wide surveys reported that among six men, one will be
diagnosed as prostate cancer, during his lifetime. It is well
known that such neoplasm occurs mainly in older men; about
two thirds are diagnosed after the age of 65, it is uncommon
before age 40. Age of 67 is considered average age at the time
of diagnosis. It is considered the second leading cause of cancer
death in American men, following bronchial carcinoma; about
1 man in 36 will die of prostate cancer.1
1.1. Risk factors for prostate cancer
Some factors might be associated with increased risk of pros-
tate cancer, although such link is not yet clearly explained.
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Prostate cancer is very rare in men younger than 40, but the
chance of having prostate cancer rises rapidly after age 50. Al-
most 2 out of 3 prostate cancers are found in men over the age
of 65.
1.1.2. Race/ethnicity
Prostate cancer occurs more often in African-American men
than in men of other races. African–American men are also
more likely to be diagnosed at an advanced stage, and are
more than twice as likely to die of prostate cancer as white
men. Prostate cancer occurs less often in Asian–American
and Hispanic/Latino men than in non-Hispanic.
1.1.3. Family history
Prostate cancer seems to be of high incidence in some families,
which suggests that there may be an inherited or genetic factor.
Having a ﬁrst degree relative with prostate cancer doubles the
risk of developing such disease. Also, the risk is much higher
for men with several affected relatives.
1.1.4. Genes
Some inherited genes had been found to raise the risk for more
than some type of cancer. For example, inherited mutations of
the BRCA1 or BRCA2 genes are the reason that breast and
ovarian cancers are much more common in some families.
Mutations in these genes may also increase prostate cancer risk
in some men, but they account for a very small percentage of
prostate cancer cases.1–3
1.2. Clinical picture
The majority of prostate cancers are incidentally diagnosed in
patients who are asymptomatic in the screening programs of
prostate-speciﬁc antigen (PSA) level or ﬁndings on digital
rectal examination. Some patients with prostate cancer may
present with urinary complaints or retention, back pain, hema-
turia, frequency, urinary urgency, and decreased urine stream.
However, these symptoms often result from benign prostatic
hyperplasia (BPH).4,5
Manifestations of advanced disease result from combina-
tion of lymphatic, hematogenous, or contiguous local spread.
Skeletal manifestations are especially common, because metas-
tasis of prostate cancer has a strong osseous predilection.
These advanced signs include weight loss and loss of appetite,
anemia, bone aches, with or without pathologic fracture, and
neurologic deﬁcits from spinal cord compression. Also, lower
extremity pain and edema due to obstruction of venous and
lymphatic tributaries by nodal metastasis may be encountered.
Uremic symptoms can occur from ureteral obstruction caused
by local prostate growth or retroperitoneal adenopathy
secondary to nodal metastasis.4,5
1.3. Pathophysiology
Adenocarcinoma is the most common type (95%). Approxi-
mately 4% of cases is transitional cell, which is thought to
arise from the prostatic urethra epithelium. Squamous cell
carcinomas constitute less than 1% of all prostate carcinomas.
In many cases, prostate carcinomas with squamousdifferentiation arise after radiation or hormone treatment.
The few cases that have neuroendocrine morphology are
believed to arise from the neuroendocrine stem cells normally
present in the prostate. Of prostate cancer cases, 70% arise in
the peripheral zone, 15–20% arise in the central zone, and
10–15% arise in the transitional zone. Most prostate cancers
are multifocal, with synchronous involvement of multiple
zones of the prostate.3,5
1.4. Diagnostic tools
1.4.1. Transrectal US (TRUS)
TRUS is usually the ﬁrst applied imaging modality for diagno-
sis of prostate cancer. It can show the focal prostatic lesion and
guide transrectal biopsy. Also, it can evaluate the layers of the
rectal wall to determine the depth of tumor penetration and
demonstrate the regional lymphadenopathy, if present. So, it
can help in staging of prostate cancer, however as with all
ultrasound examinations, it is operator dependent. There are
many advantages that make TRUS the ﬁrst and commonest
applying imaging modality e.g. it is less expensive than mag-
netic resonance imaging (MRI); it is portable and not time
consuming. Also, TRUS is well-tolerated by patients, and
involves no radiation exposure.6,7
1.4.2. CT scan
CT scan has almost no role in the initial diagnosis of prostate
cancer, due to poor tissue contrast between the prostate and
the surrounding levator ani. Also, the prostatic spatial resolu-
tion is of limited value, so its internal anatomy is not well dem-
onstrated. The major role of CT is in the nodal staging of
prostate cancer, so that CT should be performed only in
patients with a PSA level greater than 20, when it is possible
to have advanced malignancy with nodal deposits. CT sensitiv-
ity for diagnosis of nodal deposits ranges around 36%, because
of the missed microscopic ones. One of the beneﬁts of CT scan
is its high sensitivity, as guiding imaging modality in nodal
biopsy. Also, CT scan is sensitive for early detection of osseous
deposits, long before X-ray can do.8,9
1.4.3. Radionuclide bone scanning
Scintigraphy still remains the examination of choice for
diagnosis of prostatic osseous deposits, which are frequently
encountered complication even in symptom free patients. Bone
scan is not strictly indicated for patients with PSA below
10 ng/mL., this is because chances of a positive bone scan
are less than 1%. The incidence of osseous deposits increases
in conjunction with PSA level, becoming more than 50% if
PSA level is above 50 ng/mL. Prostatic bony deposits are com-
monly osteoplastic showing avid tracer uptake; however the
less commonly reported osteopenic type may reﬂect extensive
damage to bone with little osteoblastic activity.9
1.4.4. MRI
MRI had been proven to be an important imaging tool in the
diagnosis of prostate cancer. MRI shows clear a delineation of
the prostate as well as its high spatial resolution quality as
regards demonstration of the internal zonal anatomy. Thus,
it can show clear anatomical differentiation between the
peripheral and transitional zone. In addition, MRI also allows
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weighted MRI (DWI), MR spectroscopy (MRS), and dynamic
contrast enhanced MRI (DCE-MRI).
1.4.5. Normal MRI prostate
The prostate gland extends from the bladder base to the uro-
genital diaphragm with inverted pyramid like conﬁguration.
The prostate can be divided into ﬁve zonal sectors: non-glan-
dular anterior ﬁbromuscular stroma, peripheral zone (70%),
central zone (25%), transition zone (5%) and periurethral
glandular tissue (thin rim). T2-weighted sequence is considered
the most informative sequence as regards demonstration of
this zonal anatomy. The signal intensities in the central and
transition zones show relative hypointense signal in compari-
son with high signal peripheral zone, surrounded by a thin
rim of low signal intensity representing the ﬁbrous capsule.
The anterior ﬁbromuscular stroma has also low signal
intensity.9,10
The transition and central zones show similar intensity, so,
they could be only differentiated by their assumed location.
The transition zone extends from the bladder neck anterosupe-
riorly toward the verumontanum posterolaterally, anterior to
the urethra. Central zone bounds on the posterior surface of
the transition zone and proximal urethra and encloses the ejac-
ulatory ducts. The periurethral zone, transition zone and cen-
tral zone are collectively called central gland. Also, linear
signal voids are seen posterolateral to the capsule, representing
neurovascular bundles. Newly introduced functional MRI
sequences; namely Diffusion weighted image (DWI), MR spec-
troscopy (MRS) and dynamic contrast studies are being eval-
uated for accurate early diagnosis of prostatic carcinoma.9,10
2. Patients and methods
2.1. Study population
This is a prospective study which aims to check the sensitivity
of phased array surface coli of 3T MRI, in pre-sampling diag-
nosis of prostate cancer in 20 consecutive patients. It was done
in Almana General Hospital (AGH)-Eastern Province-KSA,
where a newly introduced 3T MRI (Siemens-Magnetom Verio
3T-Siemens medical solution-Erlangen-Germany), which was
used in this study. This study was done in an attempt to
replace the commonly used endocavitary rectal coil with sur-
face coli, which is more acceptable by patients, if proven to
be of similar or nearby sensitivity.
Screening program with annual PSA test for all hospital
male clients, above age of 50 was established many years ago
in AGH. MRI followed by TRUS guided biopsy was routinely
recommended for anyone who has age-speciﬁc unexplained
elevated PSA. PSA level judgment was done, according to
the international agreed standard normal values for differentTable 1 Age speciﬁc normal PSA.
Age group (Years) Normal PSA value (ng/ml)
50–60 3
60–70 4
70–80 5age groups. Also MRI was done for any patient, regardless
of his age group, with high PSA velocity i.e. rapid unexplained
rising serum PSA level (> 0.4–0.75 ng/ml/yr.)11 Table 1.
Through OSRIX PACS system (Picture Archiving and
Communication System), the DICOM images were transferred
to and stored in mother computer, with high storage capacity.
Access to these images can be easily done with RIS (radiology
information system). Also, all laboratory ﬁndings, histopathol-
ogical results, medical or surgical history if any were clearly
reordered for all patients.
2.2. Technique
MRI examinations had been done using phased array surface
coil with ﬁxed sequence parameters. Sequences include coro-
nal, sagittal and axial T2w and axial T1w sequences, dynamic
contrast study (DCE-MRI 3D fastﬁeld echo sequence
(3DFES)), diffusion weighted images and MRS. In DCE,
0.1-mmol/kg bolus of Gadodiamide (Omniscan, GE Health-
care AS, Oslo, Norway) was administered at a rate of
1.5 mL/s followed by a 20-mL saline ﬂush using a power injec-
tor. Images were acquired before contrast and at 30, 60, and
180 s after the contrast injection was initiated. Table 2.
DWI was obtained using EPI (echoplanar imaging) with
single-shot free breathing sequence, utilizing proton water dif-
fusion properties to produce image contrast, with b-values 0
and 1000 s/mm2, in an attempt to demonstrate the characteris-
tic restricted diffusion of prostate cancer. MRS was done
through water- and lipid-suppressed double spin-echo point-
resolved spectroscopy (PRESS) sequence. Axial T2-weighted
images were used as localizer, to select the PRESS volume aim-
ing to maximize the coverage of the prostate while minimizing
the inclusion of periprostatic fat and rectal air. The scan direc-
tion in the z-axis was angled anteriorly from (0 to 25) follow-
ing the anatomical orientation of the gland, in this direction.
Careful target localization was usually attempted especially,
in tumors at the periphery of the gland at the prostate-rectum
and prostate-periprostatic fat interface. Table 2.
2.3. MRI analysis
The two consultant radiology authors reviewed the images of
this study, ﬁrst individually, and then dual discussion was
made shortly after the separate evaluation. Results of T2w se-
quence alone were reordered ﬁrst separately and then collec-
tively in different combination groups that were divided
according the other types of sequences added to the initial
T2w sequence. So, results of the study were recorded under
four different sequence combinations for efﬁcacy comparison.
These groups were T2w sequence results alone at ﬁrst, then in
combination with DWI results in the second group, DCE was
added in the third and lastly MRS was added in the fourth.
Table 3. These sequences are the most widely used MRI
sequence for prostatic images, as published in many new
literatures.9,10
Non contrast T1w sequences have regional compromised
tissue contrast resolution, so it was only used to check for hem-
orrhage if any. In DCE sequences, the previously published lit-
eratures reported four different patterns of enhancement; no
enhancement, gradual enhancement (slow wash in), early and
prolonged enhancement (rapid wash-in, delayed washout)
Table 2 MRI sequences parameters.
Sequence TRTE (msec) FOV(mm) Matrix Slice thickness(mm) Flip angle
Axial T2w 2600/100 100 512 · 512 3 65
Coronal T2w 2600/100 100 512 · 512 3 90
Sagittal T2w 2800/100 100 512 · 512 3 90
Axial T1w 550/10 100 512 · 512 3 65
DCE-MRI (3DFES 3.3/1.6 100 256 · 256 3 10
DWI (b value: 0–1000 s/mm2) 2800/80 30 128 · 128 3 90
MRS 1000/100 90 72 · 72 6 90 /180 /180 80
Table 3 Diagnostic sensitivity percentages of the different sequence combinations.
Sequence True +ve True-ve False +ve False-ve Sensitivity % Speciﬁcity % PPV% NPV %
T2w 9 4 1 6 60 80 90 40
T2w+DW 10 4 1 5 66.6 80 90.9 44.4
T2w+DW+DCE 13 4 1 2 86.6 80 92.8 66.6
T2w+DW+DCE+MRS 14 5 0 1 93.3 100 100 83.3
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rapid washout). Rapid wash-in and early washout is the stan-
dard enhancement pattern of malignant prostatic tumors,
while benign lesions usually show no or delayed wash-in as
well as delayed washout enhancing pattern.12
On diffusion weighted images (DWI), malignancy was con-
sidered when lesions show obvious restricted diffusion, which
is seen as hyperintense signal in DWI and hypointense signal
in apparent diffusion coefﬁcient (ADC). This sequence was ap-
plied in the three orthogonal planes with b-values of 0 and
1000 s/mm2 13,14 In MRS, high choline/creatine levels and
depletion of citrate level are the standard criteria of malig-
nancy. The mean normal choline-creatine/citrate ratio is
<0.5, it is considered suspicious for malignancy if >0.5 and
very suspicious if >0.8.13
Results of the MRI were recorded in stamped sheets before
availability of pathological results.
3. Results
Prostate cancer was correctly reported by T2w sequence within
9 patients (45%), 10 patients by combined interpretation of
DW&T2w sequences (50%), 13 patients by combined T2w –
DW- DCE (65%) and 14 patients by combination of T2w-
DW-DCE-MRS sequences (70%). Correct exclusion of
prostate cancer was made through T2w images in 4 patients
(20%), by T2w and DWI in through T2w images in 4 patients
(20%), by T2w, DWI and DCE images in 4 patients (20%),
and T2w, DWI and DCE and MRS separately and in all other
combinations in 5 patients (25%).
MRI examinations were incorrectly negative in 6 (30%), 5
(25%), 2 (10%) and only one patient (5%). Sensitivity of cor-
rect diagnosis was 60%, 66.6%, 86.6% and 93.3%. Speciﬁcity
was 80%, 80%, 80% and 100%. Positive predictive value
(PPV) was 90%, 90.9%, 92.8% and 100%. Negative predictive
value (NPV) was 40%, 44.4%, 66.6% and 83.3%. These re-
sults were recorded in T2w alone, T2w + DWI,
T2w + DW+DCE and T2w +DW+DCE+MRS,respectively. Also, incorrect positive diagnosis of prostate can-
cer which had been excluded by biopsy was encountered in
only one patient (5%) with T2w alone, T2w and DW together,
and T2w +DW+DCE sequences. Table 3. Chart 1.
Pathological results of US guided transrectal biopsies were
prostate cancer in 15 patients (75%), BPH in 3 patients (15%),
and bacterial prostatitis in one patient (5%) and non-bacterial
prostatitis in another one (5%). In these groups, the average
PSA levels were 16.7, 5.4, 8.5, 6.7 ng/dl, respectively. Table 4.
4. Discussion
MRI examination of the prostate gland was performed as
per standard procedures through the use of endorectal coil
(ERC) at 1.5 T MRI apparatuses, in an attempt to obtain
a sufﬁciently high signal-to-noise ratio with subsequent good
spatial resolution to allow clear demarcation of any prostatic
focal lesion. The location, signal changes, pattern of growth
and extension were the standard criteria for suggestion of
the pathological diagnosis of prostatic swellings. At 3T
MRI, considering increased magnet power, it is expected
to have increased signal-to-noise ratio with body or surface
phased array coils. So studies to check accuracy and sensi-
tivity of imaging with these surface coils were in need to re-
place ERC which was not easily tolerated by considerable
number of male patients.
Our study included 20 male patients (50–80y), who were
clinically suspected to have prostate cancer due to lower uri-
nary tract symptoms in combination with age group speciﬁc
high PSA. We tried to apply all possible valuable sequences
that may help increasing the sensitivity of diagnosis with such
easily tolerated coils. MRI sequences that were applied in this
study were T2w, DW, DCE and MRS, in different groups
combination, namely T2w alone, T2w and DWI, T2w, DWI
and DCE and lastly, all together. Criteria of diagnosis of pros-
tate cancer in each sequence were carefully evaluated by the
two radiology authors and compared with the standard imag-
ing criteria of standard normal prostate MRI model. (Fig. 1).
Chart 1 Representation of different diagnostic sensitivity percentages of different sequences combination.
Table 4 TRUS biopsy results with PSA average of the
different groups.
Pathological diagnosis No. Average PSA ng/dl
Prostate cancer 15 (75%) 16.7
BPH 3 (15%) 5.2
Bacterial prostatitis 1 (5%) 8.5
Non-bacterial prostatitis 1 (5%) 6.7
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rectly diagnosed, while 4 cases were also correctly excluded.
False positive results were recorded as one positive and 6 neg-
ative cases. These ﬁndings give records of 60% sensitivity, 80%
speciﬁcity, 90% PPV and 40% NPV. This result could be ex-
plained by the variable diagnostic sensitivity of T2w images,
according to regional location of the lesions. Peripheral zone
cancer foci were clearly recognized as ill-deﬁned low-signal-
intensity lesions with or without extracapsular extension. This
clear identiﬁcation of malignant tumors in peripheral zone
could be explained by the regional contrast difference between
MRI signals of normal glandular tissue and malignant tissue.
Peripheral zone of prostate, which comprises 70–80% of the
glandular tissue, exhibits diffuse homogenous intense bright
signal in T2w sequence, due to high acinar and ductal ﬂuid
contents. So, compact non glandular malignant tissue which
displays obvious T2w low signal could be easily localized at
this peripheral zone in contrast to the normal high T2w signal.
Fortunately more than 70% of prostate cancer develops at this
zone, hence the importance of T2w sequence in diagnosis of
prostate cancer.15 (Fig. 2A and B) Also these recognized
peripheral zone lesions were obviously documented by positive
ﬁndings of these lesions in DWI and DCE images. (Fig. 2 C
and D).
On the contrary, central and transitional zones display low
or heterogeneous T2 signal intensity since due to fewer glandu-
lar structures and smooth muscles, so there is a clear demarca-
tion between them and the peripheral zone with sharp
interface, called psuedocapsule. However, central and transi-
tional zones ca not be differentiated form each other on top
of MRI signal basis, only by assumed location of each lobe.
Owing to their normal signal heterogeneity, tumors could
not be clearly outlined by T2w sequence alone, hence the need
for additional helpful MRI sequences. (Fig. 3A) This matches
with what is described by Cheikh et al. in a study published in
2009 in European Radiology Journal.16
Diffusion-weighted MRI (DWI) has been implied for imag-
ing of extra-cranial structures since the 1990s, due to theadvent of high resolution short sequences like echo-planar
imaging (EPI). DW-MRI provides information about the
molecular movement of water in biological tissues. Diffusion
of water within the body is impeded by cell membranes, so
the neoplastic compact cellular tissues signiﬁcantly restrict
the motion of extracellular water. DWI alone had a score of
true positive diagnosis of 10 cases and true negative exclusion
of 3 cases. Fallacious results of DWI were recorded as wrong
negative exclusion of 5 cases and false positive diagnosis of 2
cases. This gives indices of 66.6% sensitivity, 60% speciﬁcity,
100% positive predictive value and 37.5% of negative predic-
tive value.
Restricted diffusion in the three orthogonal planes was
expressed as DWI high signal intensity in comparison of the
low signal intensity of the normal prostatic tissue. However
some overestimation of the restricted diffusion could be seen
in issues with long T2 relaxation time, which is termed T2
shine through. This could be avoided through review of
ADC map, which shows restricted diffusion as low signal
intensity avoiding T2 shine through contamination. (Figs. 2C
and 3B). So, such application of this short time sequence can
correct some falacious negative results of T2w images, alone
at central zone. This also agrees with what was described by
Kim in study published at June 2010 in American Journal of
Roentgenology (AJR).17
Its short acquisition time makes it easy to be routinely in-
cluded in prostate imaging protocols and also, it can help in
early detection of tumor recurrence. It may help checking re-
sponse for treatment and it can also guide biopsy intake from
the most compact cellular part of the tumor. However, DWI
has some limitations such as non-standardized ADC proto-
cols, image distortion and susceptibility artifacts that may limit
sensitivity of DWI especially in follow up studies for evalua-
tion of the therapeutic responses. So application of more ad-
vanced software and hardware is needed to overcome such
problems.17 Also, DWI has some speciﬁcity limitation because
of overlap between some compact cellular lesions of different
pathology e.g. Some types of BPH and prostatitis may have al-
tered cellular density and interstitial pressure, so they can mi-
mic prostate cancer on DWI.18
Application of dynamic contrast enhanced MRI (DCE-
MRI) intends to demonstrate the characteristic neoplastic
new angiogenic effect, through demonstrating altered pattern
of enhancement after contrast injection in tissues over short
period of time. The enhancement intensity at ROI is expressed
through post-processing workstation, as intensity-time curve
chart. Angionetic effect of neoplastic process leads to early
enhancement and early washout of neoplastic tissue, rather
Figure 1 Standard MRI of normal prostate. (A) T2w, (B) ADC, (C) DCE axial image and (D) MRS.
Figure 2 (A) Axial T2w image and (B) Axial T2w Fat Sat. image show right sided peripheral zone unencapsulated hypointense lesion.
(C) Axial ADC image shows signiﬁcant diffusion restriction within the lesion. (D) Axial DCE arterial phase shows early avid enhancement
of the swelling simulating the enhancement of the central zone. (Arrow)
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Figure 3 Pathologically proven prostate cancer. (A) Coronal T2w image showing no masses in the central zone. (B) ADC axial image
shows left paramedian central zone focal lesion with restricted diffusion. (C) DCE arterial phase axial images show early arterial
enhancement of the lesion. (Arrow in B&C).
Figure 4 (A) T2w and (B) ADC axial images show no abnormalities, while MRS (C) shows a severe rise in choline-creatine/citrate ratio
(1.0) (characteristic MRS sign of malignancy) in comparison with the standard normal value (D).
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nign lesions. (Fig. 2D and 3C and D).In our study, DCE-MRI had lower scores than DWI and
T2W, with records of 7 true positive, 3 true negative, 2 false
Figure 5 (A) Axial non contrast T1w, (B) DCE Axial and (C) Axial T2w images show prostatic abscess as cystic central zone
hypointense lesion in A, with postcontrast ring enhancement in B and ﬂuid level in C. (Arrows).
118 M. Agha, A.F. Eidpositive and 8 false negative cases, 46.6% sensitivity, 60%
speciﬁcity, 77.7% PPV and 27.2% NPV. This could be ex-
plained again by limited sensitivity of DCE-MRI in diagnosis
of central zone lesions with missed some lesions, due to early
regional normal tissue enhancement masking the neoplastic
enhancement pattern. Also, it could not help in differentiating
hypovascular malignant tumors from benign tumors, as both
show slow or non-enhancement pattern. Some unavoidable
technical errors- e.g. rectal motions- may distort the relatively
long timed dynamic sequences, thus deforming the dynamic
curve. Also, some benign prostatic lesions may show high vas-
cularity, like some types of BPH, showing enhancement pat-
tern of nearby criteria to the neoplastic enhancement curves.
Similar ﬁndings were reported by Iwazawa in diagnostic and
interventional radiology journals, at 2011.19
Application of point-resolved spectroscopy (PRESS) MRS
for the targeted region of interest in the prostate results in cor-
rect diagnosis of 16 cases (11 positive and 5 negative) and false
negative exclusion of 4 patients, with 73.3% speciﬁcity, 100%
sesitivity,100% PPV and 55% NPV. These results had raised
the scores of sensitivity of MRI examinations using surface
coils with 3 T MRI, relying upon demonstration of increased
levels of speciﬁc metabolites formed by the neoplastic growth.
The normal prostatic MRS shows high citrate and low choline-
creatine spectra. Choline metabolite peak resonant spectrum is
so close, commonly indistinguishable from the choline peak
and expressed as one spectrum. Cancer cells utilize citrate oxi-
dizing metabolism with high turnover of phospholipids raising
the choline level and suppressing citrate level, thus there will beincrease the choline-creatine/citrate ratio more than 0.513
(Fig. 4).
The false negative results could be explained by the small in
size of the lesions, so signals from surrounding normal tissues
overlap the neoplastic signals. This agrees with study published
by Verma S. in American Journal of Roentgenology (AJR) at
June 2010.20
In summation of positive ﬁndings of T2w sequence, DWI,
DCE-MRI and MRS, 3 Tesla MRI surface coil prostatic
examination had achieved good scores of 93.3% sensitivity,
100% speciﬁcity, 100% PPV, 83% NPV. This score supported
the fact that 3T MRI imaging of prostate using phase array
surface coil is a useful diagnostic tool for detecting prostate
cancer, trusty replacing endorectal approach which was the
standard protocol for examinations done with 1.5 T. In addi-
tion to diagnosis of prostate cancer, this technique of MRI
examination through these combined sequences had been also
proven to have high sensitivity in diagnosis of non-malignant
lesions, that may clinically and even laboratory simulate pros-
tate cancer, e.g. prostatic abscess or prostatitis. (Fig. 5).Limitation of the study
Due to recent installation of the 3 tesla MRI in our hospital,
we had relatively small number of candidates suitable for this
study (20 patients). However, we plan to expand the applica-
tion of this MRI protocol in larger number of patients, on a
longer term study in the nearby future.
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None.
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